Project A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral…

Basic data

Title:
A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression
Duration:
19/10/2015 to 31/10/2016
Abstract / short description:
This study will investigate whether repeated use of intranasal esketamine plus an oral antidepressant (active comparator) plus intransal placebo in delaying relapse of depressive sympptoms in subjects with treatment-resistant depression who are stable in remission after an induction and optimization course of intransal esketamine plus an oral antidepressant.
Keywords:
Esketamin (esketamine)
depression
Depression
treatment resistance
Therapieresistenz

Involved staff

Managers

Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Epileptology
Department of Psychiatry and Psychotherapy
Hospitals and clinical institutes, Faculty of Medicine

Funders

Neuss, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.